Alnylam initiates phase III trial of revusiran in transthyretin-mediated amyloidotic cardiomyopathy Dec. 16, 2014
La Jolla Pharmaceutical and George Washington University sign license agreement relating to LJPC-501 Dec. 11, 2014
Phase I results for recombinant ApoA-I Milano/phospholipid complex as treatment of atherosclerosis Dec. 3, 2014
RSS